Sentences with phrase «many women with breast cancer»

Glenn Dubin, Highbridge Capital Management, and Kenneth Davis, Mt. Sinai Health System, discuss how the medical community is developing better ways to treat women with breast cancer.

Over the past two decades, Dr. Bear, a researcher and surgeon, has led international trials that have resulted in major changes in the treatment of breast cancer and dramatically increased the chance for breast conservation among women with breast cancer.

To commemorate the occasion, the company dedicated the entire year to The Donna Foundation, a local charity that raises funds for women with breast cancer who need assistance.

(1) Breast cancer and breastfeeding: collaborative reanalysis of individual date from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without the disease.

Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.

In another meta - study (compiling data from 47 smaller studies) published in 2002, more than 50,000 women with breast cancer and nearly 97,000 women without the disease from 30 countries were studied.

Breastfeeding Associated with Reduced Mortality in Women with Breast Cancer.

Throughout the festival, sight was restored to the blind, wheelchair - bound and crutch - aided people walked unaided, a woman with breast cancer got healed and the deaf and dumb also received hearing and speech.

Radiotherapy is still a highly effective treatment for many women with breast cancer.»

Cuomo signed a bill into law that will expand treatment options for women with breast cancer and require better access to screenings — an issue that's personal for him, due to his girlfriend Sandra Lee's battle with the disease.

Politics.co.uk has previously reported how a man in the UK died after being too afraid to visit a doctor incase he was deported, and how a woman with breast cancer refused to seek treatment for the same reason.

Breast Cancer Care is publishing recommendations on how to improve outcomes and experiences for older women with breast cancer in a new policy briefing, supported by Age UK.

Commenting on research, to be published in the July issue of The Oncologist, looking at discrimination in treatment of older women with breast cancer.

Breast Cancer Care, the leading breast cancer support and information charity in the UK, has produced a new report, backed by Age UK, that makes clear recommendations to improve outcomes and experiences for older women with breast cancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatments.

Commenting on research, to be published in the July issue of The Oncologist, looking at discrimination in treatment of older women with breast cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care, said:

An early pilot study of women with breast cancer showed that the diet resulted in better weight loss and improvement in some chronic disease risk factors compared to a lower fat diet.

«Older women with breast cancer report better cosmetic satisfaction with less radiation, less surgery.»

«Here at Valley, we are proud to offer this option for our patients and are excited about its potential for vastly improving patient care for women with breast cancer.»

In the first study evaluating patient - reported cosmetic outcomes in a population - based cohort of older women with breast cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long - term.

«It is believed that many women with breast cancer are being overtreated, which entails considerable side effects and costs.

Molecular characterization of the cells that undergo cell fate transition upon oncogenic Pik3ca expression demonstrated a profound oncogene - induced reprogramming of these newly formed cells and identified gene expression signatures, characteristic of the different cell fate switches, which was predictive of the cancer cell of origin, tumour type and clinical outcomes in women with breast cancers.

The hormone, 17α - methyltestosterone (MT), is sometimes prescribed for men with testosterone deficiencies and older women with breast cancer.

«Isoflavones in food associated with reduced mortality for women with some breast cancers.»

An epidemiological analysis of data from more than 6,000 American and Canadian women with breast cancer finds that post-diagnosis consumption of foods containing isoflavones — estrogen - like compounds primarily found in soy food — is associated with a 21 percent decrease in all - cause mortality.

Around 15 per cent of women with breast cancer have this form of the disease, in which tumour cells lack the three receptors that most drugs target.

«Every woman with breast cancer is now tested for that gene.

Isoflavones have been shown to slow the growth of breast cancer cells in laboratory studies, and epidemiological analyses in East Asian women with breast cancer found links between higher isoflavone intake and reduced mortality.

The authors note that prior studies have reported elevated levels of distress among people with cancer, but they vary in quality due to small sample sizes, different diagnostic criteria and assessment standards, and an over-representation of women with breast cancer.

The team gave 137 women with breast cancer either T - DM1 or the standard treatment of Herceptin plus another drug, docetaxel.

Initially used to protect against side - effects such as fractures, there is also some evidence that taking the drug extends the lives of women with breast cancer.

Li says he and colleagues at the Fred Hutchinson Cancer Research Center and the University of Washington found the correlation between migraines and breast cancer during a survey of 2,000 post-menopausal women with breast cancer and 1,500 post-menopausal women with no history of breast cancer.

Overall, 35 percent of women with breast cancer expressed a strong desire for genetic testing, but 43 percent of those women did not have a relevant discussion with a health care professional.

Recent studies have shown an increase in women with breast cancer choosing this more aggressive surgery, called contralateral prophylactic mastectomy, which raises the question of potential overtreatment among these patients.

An analysis of mutations in the BRCA1 and BRCA2 genes reveals that women with breast cancer and women with ovarian cancer harbored mutations in different regions of the genes.

They found that women with breast cancer had higher levels of some types of bacteria, including Enterobacteriaceae, Staphylococcus and Bacillus.

A 2005 study showed that 92 percent of nearly 3,000 women with breast cancer who walked or did other exercise three to five hours weekly were still alive 10 years after their diagnosis, compared with 86 percent of those who exercised less than an hour a week.

Women with breast cancer or who have had both ovaries removed were not included in the study.

Currently, most women with breast cancer are treated with breast - conserving surgery followed by radiation to the whole breast.

Since 1994, many thousands of women with breast cancer from families severely affected with the disease have been tested for inherited mutations in BRCA1 and BRCA2.

A group of researchers at the University of Helsinki in Finland thought NQO1 could also be a promising predictor of survival for women with breast cancer.

ACT UP can justly be proud of what it has achieved in AIDS: it is a tribute to their work that other health groups, such as people with diabetes and women with breast cancer, are now joining them at meetings in New York to learn their campaigning methods.

«In addition to having a higher prevalence of triple - negative breast cancers than Caucasian women — something that has been documented in previous studies — we found that African American women with breast cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH Cancer Center, lead author of the study.

Breast tissue from women with breast cancer contains higher levels of compounds that can damage DNA, according to a new study.

«African American women with breast cancer less likely to have newer, recommended surgical procedure.»

The results show no increase in the risk of locoregional or systemic recurrence in women with breast cancer who undergo breast reconstruction with lipofilling.

In some women with breast cancer treated with neoadjuvant therapy, no residual invasive cancer can be detected in breast tissue samples and lymph nodes removed during surgery.

Up to 60 % of women with breast cancer also have depression, and that figure generally holds true for other cancers.

Interestingly, the team found that radiologists could do better than chance in discriminating breast cancer cases from normal tissue, even when the images of abnormal breast tissue did not directly capture a cancerous lesion or when those images were taken from the contralateral breast (the breast on the other side of the body) of a woman with breast cancer.

The study *, published in the British Journal of Cancer ** today (Wednesday), showed a potential link between the activity of a gene called BCAR4 and the likelihood that a breast cancer tumour will not respond to tamoxifen — widely used to treat women with breast cancer.

But black women with breast cancer are not getting the care they need.